Shocking Retatrutide Results Show Double Ozempic Weight Loss
Retatrutide helped adults with type 2 diabetes lose more than twice as much weight as high-dose Ozempic in an 80-week clinical trial.
Retatrutide helped adults with type 2 diabetes lose more than twice as much weight as high-dose Ozempic in an 80-week clinical trial.
Eli Lilly’s new weight loss drug, Retatrutide, cleared crucial trials, showing significant weight loss potential that could impact obesity treatment.